 |
市場調査レポート
商品コード
1454169
ヘリコバクター・ピロリ菌診断の世界市場規模、シェア、成長分析、最終用途別、診断検査別、技術別-産業予測、2024～2031年Global Helicobacter pylori H. pylori Diagnostics Market Size, Share, Growth Analysis, By End use(Hospital, Clinics), By Diagnostic Tests(Blood test, stool test), By Technology(Immuno diagnostic, Molecular diagnostic) - Industry Forecast 2024-2031 |
||||||
| ヘリコバクター・ピロリ菌診断の世界市場規模、シェア、成長分析、最終用途別、診断検査別、技術別-産業予測、2024～2031年 |
|
出版日: 2024年03月09日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
ヘリコバクター・ピロリ菌診断の世界市場規模は、2022年に5億8,768万米ドルと評価され、2023年の6億2,300万米ドルから2031年には9億9,372万米ドルに成長し、予測期間（2024～2031年）のCAGRは6.01%で成長する展望です。
ヘリコバクター・ピロリ（H.ピロリ）診断の人気の高まりは、診断の改善、効果的な治療、コスト削減を提供し、医療における重要な進歩を示しています。診断検査によってピロリ菌感染を迅速に発見することは、疾患の進行を食い止め、合併症を最小限に抑える上で極めて重要な役割を果たします。これらの検査は、胃や腸におけるピロリ菌の存在を正確に特定し、医療従事者による適切な治療の適時開始を可能にし、最終的には患者の転帰を向上させる。早期介入は症状を緩和し潰瘍の治癒を早めるだけでなく、胃がんなどの重篤な合併症のリスクも軽減します。血液検査、呼気検査、便中抗原検査など、ヘリコバクター・ピロリ菌診断市場で利用可能な多様な非侵襲的診断オプションは、費用対効果を維持しながら、患者の快適さと利用しやすさを保証し、その結果、より多くの人々にその適用範囲を広げています。さらに、抗生物質から酸を減少させる薬剤に至るまで、数多くの治療法がピロリ菌感染症に対する非常に有効な解決策を提供しています。これらの感染症に効果的に対処することで、患者は症状の緩和を得るだけでなく、潰瘍や胃がんのような潜在的な合併症を回避し、全体的な健康を増進することができます。また、効果的な治療戦略は、ピロリ菌に関連する一般的な合併症である消化性潰瘍の発症に対する予防策としても機能するため、胃粘膜穿孔のような衰弱症状や重篤な転帰の発生を最小限に抑えることができます。全体として、ピロリ菌の診断と治療の統合は、積極的な医療管理へのパラダイムシフトを強調し、より良い健康的効果と経済効率を促進します。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
ヘリコバクター・ピロリ菌診断の世界市場：最終用途別
- 市場概要
- 病院
- クリニック
- 研究機関など
ヘリコバクター・ピロリ菌診断の世界市場：診断検査別
- 市場概要
- 血液検査
- 便検査
- 呼気検査
- 内視鏡検査など
ヘリコバクター・ピロリ菌診断の世界市場：技術別
- 市場概要
- 免疫診断
- 分子診断
- 組織診断など
ヘリコバクター・ピロリ菌診断の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Abbott Laboratories
- Allergan plc
- AstraZeneca plc
- Bayer AG
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Halyard Health, Inc.
- Hologic, Inc.
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer, Inc.
- Quidel Corporation
- Sanofi S.A.
- Seegene Inc.
- Siemens Healthineers AG
- Thermo Fisher Scientific, Inc.
- Trinity Biotech plc
- ZEUS Scientific, Inc.
Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 587.68 million in 2022 and is poised to grow from USD 623 million in 2023 to USD 993.72 million by 2031, growing at a CAGR of 6.01% during the forecast period (2024-2031).
The rise in popularity of Helicobacter pylori (H. pylori) diagnostics marks a significant advancement in healthcare, offering improved diagnosis, effective treatment, and cost reduction. Swift detection of H. pylori infections through diagnostic tests plays a pivotal role in halting disease progression and minimizing complications. These tests accurately identify the presence of the bacteria in the stomach or intestines, enabling timely initiation of appropriate treatment by healthcare providers, ultimately enhancing patient outcomes. Early intervention not only alleviates symptoms and accelerates ulcer healing but also mitigates the risk of severe complications, such as stomach cancer. The diverse array of non-invasive diagnostic options available in the H. pylori market, including blood, breath, and stool antigen tests, ensures patient comfort and accessibility while remaining cost-effective, thus extending their reach to a broader population. Furthermore, the plethora of treatment modalities, ranging from antibiotics to acid-reducing medications, offers highly efficacious solutions for combating H. pylori infections. By addressing these infections effectively, patients not only find relief from symptoms but also avert potential complications like ulcers and stomach cancer, thereby enhancing overall well-being. Effective treatment strategies also serve as a preventive measure against the development of peptic ulcers, a common complication associated with H. pylori, thus minimizing the occurrence of debilitating symptoms and serious outcomes like stomach lining perforation. Overall, the integration of H. pylori diagnostics and treatment underscores a paradigm shift towards proactive healthcare management, fostering better health outcomes and economic efficiency.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter pylori H. pylori Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Helicobacter pylori H. pylori Diagnostics Market Segmental Analysis
Global Helicobacter pylori H. pylori Diagnostics market is segmented based on Diagnostic tests, technology, end-user, biomarker, and region. By end use, the Helicobacter pylori H. pylori Diagnostics Market is segmented into hospitals, clinics, research institutes, and others. By Diagnostic tests, the Helicobacter pylori H. pylori Diagnostics Market is segmented into Blood test, stool test, breath test, endoscopy, and others. By Technology, the Helicobacter pylori H. pylori Diagnostics Market is segmented into Immuno diagnostics, molecular diagnostics, Histology, and others. By region, the Helicobacter pylori H. pylori Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Helicobacter pylori H. pylori Diagnostics Market
The market for H. pylori thrives on the widespread prevalence of H. pylori infections worldwide, affecting an estimated half of the global population and ranking among the most prevalent bacterial infections. Consequently, there's an escalating demand for diagnostic tests and treatment solutions driven by the necessity for accurate diagnosis and effective management of the infection.
Restraints in the Global Helicobacter pylori H. pylori Diagnostics Market
The global market for H. pylori is buoyed by its widespread prevalence, with approximately half of the world's population affected by these infections, making it one of the most common bacterial infections globally. This prevalence fuels a growing demand for diagnostic tests and treatment options as healthcare systems strive to accurately diagnose and manage the infection effectively.
Market Trends of the Global Helicobacter pylori H. pylori Diagnostics Market
The market for H. pylori infection is experiencing a growing demand for non-invasive diagnostic methods like serology tests and urea breath tests. These alternatives are gaining popularity thanks to their minimal invasiveness and user-friendly design, driving a notable increase in their adoption.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Helicobacter pylori H. pylori Diagnostics Market by End use
- Market Overview
- Hospital
- Clinics
- research institutes and others
Global Helicobacter pylori H. pylori Diagnostics Market by Diagnostic Tests
- Market Overview
- Blood test
- stool test
- breath test
- endoscopy and others
Global Helicobacter pylori H. pylori Diagnostics Market by Technology
- Market Overview
- Immuno diagnostic
- Molecular diagnostic
- Histology and others
Global Helicobacter pylori H. pylori Diagnostics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Halyard Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Seegene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ZEUS Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
